50 phenotypes from 3 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi involves: 129P2/OlaHsd * C57BL/6J	abnormal cauda epididymis morphology	J:227516
	abnormal corneal epithelium morphology	J:227516
	abnormal decidualization	J:227516
	abnormal epididymis morphology	J:227516
	abnormal postimplantation uterine environment	J:227516
	abnormal sperm number	J:227516
	abnormal sternum morphology	J:227516
	abnormal uterus morphology	J:227516
	abnormal vas deferens morphology	J:227516
	absent Meibomian glands	J:227516
	asymmetric sternocostal joints	J:227516
	blepharitis	J:227516
	decreased abdominal adipose tissue amount	J:227516
	decreased body size	J:227516
	decreased body weight	J:227516
	decreased endometrial gland number	J:227516
	decreased sebaceous gland number	J:227516
	decreased survivor rate	J:227516
	female infertility	J:227516
	increased rib number	J:227516
	postnatal growth retardation	J:227516
	reduced male fertility	J:227516
	small uterus	J:227516
	thin endometrium	J:227516
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+ C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju	abnormal coat appearance	J:211773
	impaired pupillary reflex	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased fasting circulating glucose level	J:211773
	increased grip strength	J:211773
	increased heart weight	J:211773
Ash1ltm2b(EUCOMM)Hmgu/Ash1ltm2b(EUCOMM)Hmgu C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju	preweaning lethality, complete penetrance	J:211773
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu	glomerulonephritis	J:208213
	normal immune system phenotype	J:208213
	increased autoantibody level	J:208213
	increased circulating interleukin-6 level	J:208213
	increased circulating tumor necrosis factor level	J:208213
	increased IgA level	J:208213
	increased IgG1 level	J:208213
	increased IgG2a level	J:208213
	increased IgG2b level	J:208213
	increased IgM level	J:208213
	increased interleukin-6 secretion	J:208213
	increased susceptibility to autoimmune disorder	J:208213
	increased susceptibility to bacterial infection	J:208213
	increased susceptibility to bacterial infection induced morbidity/mortality	J:208213
	increased susceptibility to endotoxin shock	J:208213
	increased susceptibility to induced arthritis	J:208213
	increased tumor necrosis factor secretion	J:208213
	pulmonary hyperemia	J:208213